Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
ID: 337303Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/337303

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-037.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Jan 10, 2022 12:00 AM
  4. 4
    Due Nov 15, 2024 12:00 AM
Description

The National Institutes of Health is offering a grant opportunity titled "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)". This grant aims to support innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors, prevention of drug use and HIV, and health service utilization. The grant encourages the analysis of public use and other extant community-based or clinical datasets to increase our knowledge of drug using behaviors and their consequences, as well as strategies for prevention and treatment of drug abuse and HIV. The grant does not require cost sharing or matching. The deadline for application submission is November 15, 2024. For more information and to apply, please visit the following link: Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional).

Point(s) of Contact
OERWebmaster03@od.nih.gov
Files
Title
Posted
RFA-DA-22-037-Full-Announcement.html
4/10/2024
Similar Opportunities
Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)". This grant aims to support innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors, prevention of drug use and HIV, and health service utilization. The grant encourages the analysis of public use and other extant community-based or clinical datasets to increase our knowledge of drug using behaviors and their consequences, as well as strategies for prevention and treatment. The grant has a funding ceiling of $275,000 and does not require cost sharing or matching. The deadline for applications is November 15, 2024. For more information and to apply, visit the following link: [Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-037.html).
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)". This grant aims to support pilot, feasibility, or exploratory research in substance use epidemiology and health services. The research will focus on five priority areas, including responses to sudden and severe emerging drug issues, responses to emerging marijuana trends and topics related to the shifting policy landscape, responses to unexpected and time-sensitive prescription drug abuse research opportunities, responses to unexpected and time-sensitive medical system issues, and responses to unexpected and time-sensitive criminal or juvenile justice opportunities that relate to drug abuse and access and provision of health care service. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities, Indian/Native American Tribal Governments, Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities, U.S. Territory or Possession. Non-domestic (non-U.S.) Entities (Foreign Institutions) and non-domestic components of U.S. Organizations are not eligible to apply. The grant does not require cost sharing or matching requirements. The funding instrument type is a grant, and the category of funding activity is health. The maximum award ceiling is $275,000. The deadline for application submission is September 8, 2024. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-027.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-027.html). If you have any inquiries, you can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)". This grant aims to support high priority research at the intersection of HIV and substance use. The funding is open to both individual researchers and research teams, and it includes all areas of research from basic science to clinical and implementation research. The goal is to encourage innovative research projects that have the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment, and cure of HIV among people who use drugs (PWUD). The grant requires a detailed research plan, preliminary data, and a clear description of the nexus with substance use. The funding opportunity is part of the National Institutes of Health's HIV/AIDS Research Priorities. Eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The deadline for applications is August 2, 2024. For more information and to apply, visit the following website: [http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-040.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-040.html).
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)". This grant aims to support high priority research at the intersection of HIV and substance use. The funding is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. The purpose of this grant is to invite innovative research projects that have the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment, and cure of HIV among people who use drugs (PWUD). The applicants are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. The grant does not require cost sharing or matching requirements. The funding instrument type is a grant, and the category of funding activity is health. The maximum award ceiling for this grant is $1,500,000. Eligible applicants for this grant include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the federal government, faith-based or community-based organizations, Hispanic-serving institutions, historically Black colleges and universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. territories or possessions. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. The closing date for this grant opportunity is February 11, 2027. The archive date is March 19, 2027. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-060.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-060.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)". This grant aims to support clinical research projects that focus on understanding the neurobiological mechanisms underlying Substance Use Disorders (SUD) and fundamental brain function relevant to substance use. The grant utilizes a R61/R33 Phased Innovation Award mechanism and is particularly designed to support exploratory and developmental projects that require budgets exceeding those allowed for the R21 mechanism. The grant does not require cost sharing or matching. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The closing date for this grant opportunity is May 7, 2026. For more information and to apply, please visit the following link: [Exploratory Clinical Neuroscience Research on Substance Use Disorders Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-23-157.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.